Pre-clinical services from a top preclinical Contract Research Organization in Eastern Europe.
We are an independent CRO based in the USA that offers preclinical drug toxicology in top-notch, Good Laboratory Practices certified testing sites in Kiev, Ukraine. Our research laboratories are supported by the Ukrainian National Academy of Medical Sciences and Health Department and offer support for for-profit development of new medicine discoveries as part of their main purpose. Our business was created to provide the high quality, low-cost services of these facilities to new bio-technology companies in the USA and EU, thereby offering an attractive option for advancing development programs quickly and at much lower cost than other commercial Contract Research Organizations. We offer a broad range of preclinical research including medicine safety, chronic and acute toxicity, pharmacological screening, bioavailability, bioequivalence, and complete in vivo and in vitro screening for anti-cancer activity.
Our preclinical Contract Research Organization is able to price pre-clinical trials far below other CROs because we maintain a very low overhead in the USA and perform all trials in Ukraine where labor and lab costs are much lower. Our team in the USA consists only of the organization principals who deal directly with clients; we don’t have any marketing expenses other than our web site, and no main offices, supporting staff or other overhead to increase prices. We have much lower trials conduct prices in Kiev, UA due to much lower personnel rates and are able to provide our best pricing for longer and more complex preclinical trials where labor is the most significant part of the overall price. Since we use the same reliable international suppliers for lab animals, reagents and lab materials as other CROs, we don’t have any cost advantage on these items and thus less overall cost advantage for very short-term preclinical trials. However, regardless of your study protocol and duration, our goal is to provide our customers the greatest possible value for their investment.